Skip to content

Clinical trials

Carcinoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Country / region: Netherlands Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20051
20063
20071
20081
20093
20101
20112
20124
20141
20162
20172
20184
20195
20203
20215
20222
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting7
Recruiting5
Terminated5
Unknown status3
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
AstraZeneca4
Maastricht University Medical Center3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
Bayer2
Exelixis2
Hoffmann-La Roche2
Pfizer2
Radboud University Medical Center2
Steba Biotech S.A.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma47
Neoplasms20
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms11
Adenocarcinoma9
Neoplasms by Site9
Carcinoma, Renal Cell6
Neoplasms by Histologic Type6
Lung Diseases5
Neuroendocrine Tumors5

Trials

Showing 76 to 47 of 47. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.